Oxford Biomedica plc
Overview
Oxford Biomedica plc is a leading gene and cell therapy group focusing on the development and commercialization of novel gene-based therapies. With expertise in viral vector bioprocessing, the company partners with pharmaceutical and biotechnology companies to bring experimental treatments to market.
Core services & business areas
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Oxford Biomedica plc in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Oxford Biomedica plc?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.